BlackBarn Capital Partners
Latest statistics and disclosures from BlackBarn Capital Partners's latest quarterly 13F-HR filing:
- Top 5 stock holdings are SPY, RMD, ROIV, WRBY, ELAN, and represent 84.83% of BlackBarn Capital Partners's stock portfolio.
- Added to shares of these 10 stocks: SPY (+$171M), WRBY (+$44M), NIQ (+$30M), ELAN (+$22M), MH (+$9.1M), CCOI (+$5.9M), NEE (+$5.2M), PRVA, DHC, VKTX.
- Started 1 new stock position in NIQ.
- Reduced shares in these 10 stocks: RMD (-$72M), ROIV (-$29M), NXT (-$26M), TEVA (-$20M), , ACLS (-$8.3M), AMRX (-$7.8M), FBLA (-$7.5M), BVFL, ABUS.
- Sold out of its positions in BVFL, FBLA, MOH, NXT, TEVA.
- BlackBarn Capital Partners was a net buyer of stock by $101M.
- BlackBarn Capital Partners has $1.5B in assets under management (AUM), dropping by 8.84%.
- Central Index Key (CIK): 0002010204
Tip: Access up to 7 years of quarterly data
Positions held by BlackBarn Capital Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for BlackBarn Capital Partners
BlackBarn Capital Partners holds 16 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) | 67.3 | $1.0B | +20% | 1.5M | 681.92 |
|
| ResMed Put Option (RMD) | 6.3 | $96M | -42% | 400k | 240.87 |
|
| Roivant Sciences SHS (ROIV) | 4.4 | $67M | -29% | 3.1M | 21.70 |
|
| Warby Parker Cl A Com Put Option (WRBY) | 4.3 | $65M | +200% | 3.0M | 21.79 |
|
| Elanco Animal Health Put Option (ELAN) | 2.5 | $39M | +126% | 1.7M | 22.63 |
|
| Diversified Healthcare Tr Com Sh Ben Int (DHC) | 2.1 | $32M | +6% | 6.5M | 4.85 |
|
| Privia Health Group (PRVA) | 2.0 | $31M | +19% | 1.3M | 23.71 |
|
| Niq Global Intelligence Ordinary Shares (NIQ) | 2.0 | $30M | NEW | 1.8M | 16.49 |
|
| Nextera Energy (NEE) | 1.8 | $27M | +24% | 335k | 80.28 |
|
| Mcgraw Hill (MH) | 1.5 | $23M | +64% | 1.4M | 16.50 |
|
| Amneal Pharmaceuticals Com Stk Cl A (AMRX) | 1.3 | $20M | -28% | 1.6M | 12.60 |
|
| Viking Therapeutics (VKTX) | 1.3 | $19M | +10% | 550k | 35.18 |
|
| Oscar Health Cl A Put Option (OSCR) | 1.2 | $19M | +4% | 1.3M | 14.37 |
|
| Cogent Communications Hldgs Com New (CCOI) | 0.9 | $14M | +73% | 650k | 21.56 |
|
| Arbutus Biopharma (ABUS) | 0.6 | $8.9M | -7% | 1.9M | 4.81 |
|
| Axcelis Technologies Com New (ACLS) | 0.5 | $7.8M | -51% | 97k | 80.34 |
|
Past Filings by BlackBarn Capital Partners
SEC 13F filings are viewable for BlackBarn Capital Partners going back to 2023
- BlackBarn Capital Partners 2025 Q4 filed Feb. 17, 2026
- BlackBarn Capital Partners 2025 Q3 filed Nov. 14, 2025
- BlackBarn Capital Partners 2025 Q2 filed Aug. 14, 2025
- BlackBarn Capital Partners 2025 Q1 filed May 14, 2025
- BlackBarn Capital Partners 2024 Q4 filed Feb. 14, 2025
- BlackBarn Capital Partners 2024 Q3 filed Nov. 14, 2024
- BlackBarn Capital Partners 2024 Q2 filed Aug. 14, 2024
- BlackBarn Capital Partners 2024 Q1 filed May 15, 2024
- BlackBarn Capital Partners 2023 Q4 filed Feb. 14, 2024